SENECA

STUDY IDENTIFIER:

SENECA

CONDITION:

Anthracycline Induced Cardiomyopathy

CONTACT INFO:

Jane Fox, R.N.   |   Jane.Fox@allina.com   |   612-863-6289

DESCRIPTION:

This is a first-in-human study using donor stem cells on people who have decreased heart function due to anthracycline that was used to treat their cancer.

CRITERIA LIST/ QUALIFICATIONS:

This study is looking for cancer survivors who are between the ages of 18 and 79 with decreased heart function because of their cancer treatment. In order to qualify for the study, you will need to have a physical exam and a review of your medical history, lab work and a pacemaker check; if you have a pacemaker.

INVESTIGATORS:

Jay Traverse, MD

SPONSORS:

University of Texas School of Public Health

STATUS:

Open/Enrolling